GAMMA Investing LLC boosted its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 1,710.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 93,447 shares of the real estate investment trust's stock after acquiring an additional 88,285 shares during the quarter. GAMMA Investing LLC's holdings in Sabra Healthcare REIT were worth $1,633,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of SBRA. Wellington Management Group LLP lifted its stake in Sabra Healthcare REIT by 33.7% in the fourth quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock worth $55,511,000 after acquiring an additional 808,207 shares during the last quarter. Comprehensive Money Management Services LLC purchased a new position in Sabra Healthcare REIT in the fourth quarter worth approximately $333,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Sabra Healthcare REIT in the fourth quarter worth approximately $14,241,000. Jefferies Financial Group Inc. purchased a new position in Sabra Healthcare REIT in the fourth quarter worth approximately $348,000. Finally, Mackenzie Financial Corp increased its holdings in shares of Sabra Healthcare REIT by 22.1% in the 4th quarter. Mackenzie Financial Corp now owns 289,870 shares of the real estate investment trust's stock valued at $5,021,000 after acquiring an additional 52,441 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.
Sabra Healthcare REIT Stock Performance
SBRA traded up $0.14 on Wednesday, reaching $18.28. The company had a trading volume of 2,903,148 shares, compared to its average volume of 2,288,219. Sabra Healthcare REIT, Inc. has a 1 year low of $14.38 and a 1 year high of $20.03. The stock has a market capitalization of $4.35 billion, a PE ratio of 30.98, a P/E/G ratio of 1.37 and a beta of 0.85. The company has a quick ratio of 4.22, a current ratio of 4.22 and a debt-to-equity ratio of 0.89. The stock has a 50-day moving average price of $17.75 and a 200-day moving average price of $17.27.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.01. The company had revenue of $183.54 million during the quarter, compared to analysts' expectations of $180.23 million. Sabra Healthcare REIT had a return on equity of 5.14% and a net margin of 19.55%. The firm's revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.35 earnings per share. As a group, research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.
Sabra Healthcare REIT Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, May 30th. Stockholders of record on Friday, May 16th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, May 16th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.56%. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 203.39%.
Wall Street Analyst Weigh In
SBRA has been the subject of several recent analyst reports. Scotiabank boosted their target price on Sabra Healthcare REIT from $18.00 to $19.00 and gave the stock a "sector perform" rating in a research note on Monday, May 12th. Truist Financial boosted their target price on Sabra Healthcare REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a research note on Tuesday, March 18th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $19.50.
View Our Latest Report on Sabra Healthcare REIT
Insider Transactions at Sabra Healthcare REIT
In other news, Director Michael J. Foster sold 11,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total transaction of $200,420.00. Following the transaction, the director now directly owns 64,725 shares in the company, valued at approximately $1,179,289.50. This trade represents a 14.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.20% of the company's stock.
Sabra Healthcare REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
